Picture of Pharma Foods International Co logo

2929 Pharma Foods International Co Share Price

0.000.00%
jp flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapContrarian

Momentum

Relative Strength (%)
1m-1.02%
3m-27.66%
6m-53.02%
1yr-63.76%
Volume Change (%)
10d/3m-43.99%
Price vs... (%)
52w High-65.53%
50d MA-12.35%
200d MA-37.67%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital53.86%
Return on Equity63.71%
Operating Margin9.27%

Financial Summary

Year End 31st JulUnit201920202021202220232024E2025ECAGR / Avg
Total Revenue¥m10,532.8315,353.3846,75260,18568,572n/an/a53.9%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+30.28+32.35+471.24n/an/an/an/an/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Jul 202431st Jul 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Pharma Foods International Co EPS forecast chart

Profile Summary

Pharma Foods International Co., Ltd. is a Japan-based company mainly engaged in mail order business and functional materials business. The Company operates through three business segments. The Mail Order segment is engaged in the sale of supplement Tamagosamin, cosmetics Pearl Skin Lanchel and Derma QII Mild Peeling Gel, through advertising media such as televisions and radios. The Functional Materials segment is engaged in the development and sale of functional materials such as GABA, Bonepep, Folic Acid eggs and Chicken Egg Antibody. The Company is also engaged in the planning and sale of original equipment manufacturer (OEM) products such as supplements and beverages. The Biomedical segment is engaged in the antibody contract manufacture business for drug discovery and diagnostics, and life science information (LSI) business for analysis and efficacy evaluation test of materials and products.

Directors

Last Annual
July 31st, 2023
Last Interim
January 31st, 2024
Incorporated
September 12th, 1997
Public Since
June 12th, 2006
No. of Shareholders
18,519
No. of Employees
670
Sector
Biotechnology & Medical Research
Industry
Healthcare
Exchange
jp flag iconTokyo Stock Exchange
Shares in Issue
28,072,233

2929 Share Price Performance

Upcoming Events for 2929

Q3 2024 Pharma Foods International Co Ltd Earnings Release

Dividend For 2929.T - 10.0000 JPY

Similar to 2929

Picture of 3-D Matrix logo

3-D Matrix

jp flag iconTokyo Stock Exchange

Picture of AnGes logo

AnGes

jp flag iconTokyo Stock Exchange

Picture of BrightPath Biotherapeutics Co logo

BrightPath Biotherapeutics Co

jp flag iconTokyo Stock Exchange

Picture of Carna Biosciences logo

Carna Biosciences

jp flag iconTokyo Stock Exchange

Picture of Chiome Bioscience logo

Chiome Bioscience

jp flag iconTokyo Stock Exchange

FAQ